|
Cell type
|
Days
|
Number injected and tumors formed
|
|---|
| | |
1 × 106
|
1 × 105
|
1 × 104
|
1 × 103
|
1 × 102
|
|---|
|
SUM159 unsorted
|
13–100
|
5/5
|
5/6
|
5/8
|
3/8
|
0/2
|
|
SUM159 CD44+/CD24-/ESA-
|
20–100
|
8/10
|
2/2
|
1/2
|
0/8
|
0/10
|
|
SUM159 CD44+/CD24-/low/ESA+
|
20–100
|
-
|
-
|
2/2
|
6/6
|
6/10
|
|
SUM1315 unsorted
|
20–150
|
2/2
|
2/2
|
2/4
|
0/4
|
-
|
|
SUM1315 CD44+/CD24-/ESA-
|
25–150
|
3/4
|
2/2
|
0/4
|
0/10
|
-
|
|
SUM1315 CD44+/CD24-/low/ESA+
|
20–150
|
-
|
-
|
3/4
|
7/8
|
-
|
|
SUM149 unsorted
|
19–150
|
4/4
|
3/4
|
2/4
|
1/4
|
0/2
|
|
SUM149 CD44+/CD24+/ESA+
|
20–150
|
-
|
2/2
|
0/4
|
0/4
|
0/6
|
|
SUM149 CD44+/CD24-/low/ESA+
|
48–150
|
-
|
2/2
|
2/4
|
6/6
|
5/6
|
- ESA, epithelial-specific antigen.
